Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

v3.23.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid in Capital
Accumulated Deficit
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2020   4,718,714      
Beginning balance at Dec. 31, 2020 $ (7,406,164) $ 4,719 $ 14,553,438 $ (21,964,321) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 1,840,913   1,840,913    
Beneficial conversion feature 636,075   636,075    
Conversion of bridge financing (in shares)   254,425      
Conversion of bridge financing 1,908,225 $ 254 1,907,971    
Common stock repurchased (7,683,490)       (7,683,490)
Stock issuance related to offering (in shares)   6,210,000      
Stock issuance related to offering 57,351,215 $ 6,210 57,345,005    
Stock issuance related to acquisition (in shares)   202,066      
Stock issuance related to acquisition 2,000,000 $ 202 1,999,798    
Stock issued in conversion of warrants (in shares)   22,490      
Stock issued in conversion of warrants 9,996 $ 22 9,974    
Stock grant program vesting (in shares)   118,366      
Stock grant program vesting $ 0 $ 119 (119)    
Stock options exercised (in shares) 4,777 62,049      
Stock options exercised $ 386,227 $ 62 386,165    
Net loss $ (875,667)     (875,667)  
Ending balance (in shares) at Dec. 31, 2021 10,733,195 11,588,110      
Ending balance at Dec. 31, 2021 $ 48,167,330 $ 11,588 78,679,220 (22,839,988) (7,683,490)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 2,571,785   2,571,785    
Common stock repurchased (4,362,052)       (4,362,052)
Stock issuance related to acquisition (in shares)   555,390      
Stock issuance related to acquisition 3,603,813 $ 555 3,603,258    
Stock issued in conversion of warrants (in shares)   34,863      
Stock issued in conversion of warrants 0 $ 35 (35)    
Stock grant program vesting (in shares)   37,675      
Stock grant program vesting $ 0 $ 38 (38)    
Stock options exercised (in shares) 4,555 4,555      
Stock options exercised $ 28,797 $ 5 28,792    
Net loss $ (15,277,909)     (15,277,909)  
Ending balance (in shares) at Dec. 31, 2022 10,770,760 12,220,593      
Ending balance at Dec. 31, 2022 $ 34,731,764 $ 12,221 $ 84,882,982 $ (38,117,897) $ (12,045,542)